Gerstner Sloan Kettering Graduate School of Biomedical Sciences at Memorial Sloan Kettering Cancer Center

Yale University

Venture Senior Associate at RA Capital Management, L.P.

CDR-Life Inc.

Board Member

I am a Principal within the Venture team at RA Capital Management. My primary responsibility at RA Capital is to identify compelling opportunities to help facilitate new company creation or investments in emerging seed-stage companies.

RA Capital Management, L.P.

Principal

T-knife Therapeutics

Board Observer

Enara Bio

Bright Peak Therapeutics

Adcendo

Venture Senior Associate

Venture Associate

Senior Associate

Associate

Three month course on the fundamentals of entrepreneurship in biotech with a focus on evaluating the market potential of a technology, building basic financial models, funding mechanisms, intellectual property.

Worked as part of a team to develop a business plan for an institutionally developed technology, culminating in a business plan submission and presentation pitch to industry experts.

Weill Cornell Graduate School of Medical Sciences

Bench to Bedside Initiative

Studied the causes and consequences of chromosomal instability in cancer.

Identified a novel synthetic lethal relationship as a potential way to target cancer cells with chromosomal instability.

Memorial Sloan-Kettering Cancer Center

PhD Student

Profiled serum samples using mass spectrometry to identify putative prostate cancer biomarkers.

Mount Sinai Health System

Research Assistant

Dan Marks